Clinical trialNCT07341516Enrolling, by, invitationObservational

Worldwide Assessment of Deceased Donor Kidney Utilization

SponsorParis Translational Research Center for Organ TransplantationEnrollment300,000Deceased Donor Kidney TransplantKidney FailureKidney Transplant

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The persistent imbalance between kidney transplant demand and organ availability remains a major global challenge. Optimizing the utilization of kidneys from deceased donors is a critical strategy to expand the donor pool and increase access to transplantation. Previous studies have demonstrated substantial international differences in kidney acceptance and discard practices, with significant potential gains in allograft life-years through optimized utilization. However, major changes in allocation policies, donor characteristics, preservation technologies, and global events such as the COVID-19 pandemic may have altered contemporary utilization patterns. This study aims to characterize international trends in deceased donor kidney utilization, compare allograft survival across countries, and estimate potential transplantable allograft life-years gained through improved utilization practices.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Alexandre Loupy, MD, PhD
Paris Institute for Transplantation and Organ Regeneration, INSERM, UMR-S970, Paris, France
Principal Investigator
clinicaltrials.gov ↗
Peter P Reese, MD, PhD
Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, TN, USA
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France

Paris Institute for Transplantation and Organ Regeneration, Inserm, Umr-S970, Paris, France
Paris, France

United States

Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, Tn, Usa
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Nov 2025
Primary completion: 30 Nov 2026
Completion: 30 Nov 2026
Last update posted: 14 Jan 2026
Registered enrollment: 300,000
Registry id: NCT07341516

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.